ストックスクリーナーアプリを入手
31.94
1.24%
-0.40
前日終値:
$32.34
開ける：
$32.4
24時間の取引高:
725.92K
Relative Volume:
0.87
時価総額：
$13.56B
収益：
$6.18B
当期純損益:
$626.40M
株価収益率:
22.26
EPS:
1.435
ネットキャッシュフロー:
$848.81M
1週間 パフォーマンス:
-3.09%
1か月 パフォーマンス:
-11.60%
6か月 パフォーマンス:
-13.32%
1年 パフォーマンス:
+12.23%
1日の値動き範囲:
$31.79
$32.42
1週間の範囲:
$31.79
$33.52
52週間の値動き範囲:
$23.91
$38.79
Smith Nephew Plc Adr Stock (SNN) Company Profile
Compare SNN vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SNN
Smith Nephew Plc Adr
|
31.94 | 13.56B | 6.18B | 626.40M | 848.81M | 1.435 |
ABT
Abbott Laboratories
|
105.46 | 183.26B | 44.33B | 6.50B | 7.40B | 3.717 |
SYK
Stryker Corp
|
335.67 | 128.46B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
86.16 | 110.62B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
69.48 | 103.10B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
82.50 | 47.92B | 6.07B | 1.06B | 1.34B | 1.8063 |
Smith Nephew Plc Adr Stock (SNN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-12-15 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-10-14 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2025-04-25 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-03-12 | ダウングレード | UBS | Buy → Neutral |
| 2024-11-06 | ダウングレード | Berenberg | Buy → Hold |
| 2024-11-01 | ダウングレード | Deutsche Bank | Buy → Hold |
| 2024-07-24 | 開始されました | Deutsche Bank | Buy |
| 2024-06-05 | アップグレード | UBS | Neutral → Buy |
| 2023-11-28 | アップグレード | Barclays | Underweight → Equal Weight |
| 2023-11-03 | アップグレード | JP Morgan | Neutral → Overweight |
| 2023-10-31 | アップグレード | HSBC Securities | Hold → Buy |
| 2023-10-13 | 開始されました | Stifel | Hold |
| 2023-08-08 | アップグレード | UBS | Sell → Neutral |
| 2023-04-27 | ダウングレード | HSBC Securities | Buy → Hold |
| 2023-04-11 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2022-12-12 | 開始されました | Citigroup | Buy |
| 2022-11-28 | ダウングレード | UBS | Neutral → Sell |
| 2022-10-18 | 開始されました | Morgan Stanley | Equal-Weight |
| 2022-07-28 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-03-16 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-03-15 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-03-04 | アップグレード | Redburn | Sell → Neutral |
| 2021-06-09 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-18 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2020-12-01 | 開始されました | Barclays | Overweight |
| 2020-07-29 | アップグレード | BofA Securities | Neutral → Buy |
| 2020-06-04 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2020-04-14 | ダウングレード | Citigroup | Buy → Neutral |
| 2019-11-21 | 開始されました | Citigroup | Buy |
| 2019-11-12 | 開始されました | Bernstein | Outperform |
| 2019-07-23 | アップグレード | Berenberg | Hold → Buy |
| 2019-02-08 | ダウングレード | Exane BNP Paribas | Outperform → Neutral |
| 2019-01-02 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2018-12-10 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2018-11-01 | 繰り返されました | Canaccord Genuity | Buy |
| 2018-01-25 | アップグレード | JP Morgan | Neutral → Overweight |
| 2017-12-11 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2017-10-11 | 開始されました | Canaccord Genuity | Buy |
| 2017-02-27 | ダウングレード | Goldman | Buy → Neutral |
| 2017-01-19 | 開始されました | HSBC Securities | Hold |
| 2016-12-08 | アップグレード | Morgan Stanley | Equal-Weight → Overweight |
| 2016-10-06 | ダウングレード | Berenberg | Buy → Hold |
| 2016-02-26 | 開始されました | Cantor Fitzgerald | Hold |
すべてを表示
Smith Nephew Plc Adr (SNN) 最新ニュース
Smith & Nephew plc (ADR) stock faces pressure amid regulatory hurdles and slowing ortho demand - AD HOC NEWS
Smith & Nephew plc (ADR) Stock (ISIN: US83175M2052) Faces Headwinds Amid Medtech Sector Slowdown - AD HOC NEWS
[Latest] Global Surgical Stapling Devices Market Size/Share Worth USD 10.14 Billion by 2035 at a 7.2% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) - GlobeNewswire Inc.
Smith+Nephew launches next-generation ALLEVYN COMPLETE CARE Foam Dressingdesigned for high performance in wound management and pressure injury prevention - Finviz
NVIDIA Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks - InvestorPlace
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam™ Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026 - Sahm
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026 - Sahm
Smith+Nephew to feature leading rotator cuff repair portfolio including new Tendon Seam Repair System and REGENETEN◊ Bioinductive Implant at AAOS 2026 - Finviz
Smith & Nephew FTSE Healthcare Market Presence and Operational Developments - Kalkine Media
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC) to our surgeons - Finviz
Smith+Nephew signs exclusive US distribution agreement with RMR Ortho for patented technology that provides a unique dynamic compression nitinol fixation option (A'TOMIC™) to our surgeons - Sahm
Smith+Nephew signs distribution agreement with SI-BONE - Finviz
Factory Mutual Insurance Co. Buys New Stake in Smith & Nephew SNATS, Inc. $SNN - Defense World
Jim Cramer on Smith & Nephew: "This Group, I Do Not Like" - Finviz
Smith+Nephew completes acquisition of Integrity Orthopaedics; establishes unrivalled portfolio for shoulder repair - Finviz
The Truth About Smith & Nephew plc: Why This ‘Boring’ Med-Tech Stock Might Be Your Sneaky Power - AD HOC NEWS
Smith & Nephew ADR trying to close in on key technical benchmark - MSN
The Truth About Smith & Nephew plc (ADR): Wall Street Sleeper Stock or Total Snooze? - AD HOC NEWS
Smith & Nephew plc (ADR): Quiet Charts, Cautious Optimism – Is SNN a Sleeper in Medtech? - AD HOC NEWS
Smith & Nephew (SN, SNN) Stock Outlook for December 2025: Q3 Setback, $500m Buyback and What Comes Next - ts2.tech
Smith and Nephew (LON:SN) positioned across FTSE 100 Today healthcare landscape - Kalkine Media
FTSE 100 today: Pound lower; Magnum debuts, Smith & Nephew sets new goals - Investing.com
Smith & Nephew Unveils RISE Blueprint for a Stronger Future - Kalkine Media
Smith+Nephew sets ambitious growth targets through 2028 - Investing.com
Smith & Nephew (SNN) Stock Forecast 2026: Q3 2025 Results, $500m Buyback and New Board Signals - TechStock²
Smith & Nephew PLC (NYSE:SNN): A Value Investment in Medical Devices - Chartmill
[6-K] SMITH & NEPHEW PLC Current Report (Foreign Issuer) | SNN SEC FilingForm 6-K - Stock Titan
Smith & Nephew PlcDirector/PDMR Shareholding - Research Tree
REGSmith & Nephew PlcDirector/PDMR Shareholding - TradingView
Smith & Nephew stock initiated with Buy rating at Kepler Cheuvreux - Investing.com
Shell Stock Price Today (12 Nov 2025): SHEL ADR edges lower as oil slides; London closes at 2,909p amid fresh buyback and Volta Media sale - ts2.tech
Smith+Nephew shares tumble as Q3 sales miss expectations - Investing.com
Smith Nephew Plc Adr (SNN) 財務データ
収益
当期純利益
現金流量
EPS
2.19%
0.97%
大文字化:
|
ボリューム (24 時間):